Literature DB >> 3260830

A specific ELISA method for determining chloroquine in urine or dried blood spots.

V Rowell, F J Rowell, A Baker, D Laurie, A M Sidki.   

Abstract

Reported is an enzyme-linked immunosorbent assay (ELISA) that has been optimized and validated for the determination of chloroquine in urine or dried blood spots. The assay employs antisera raised in sheep to a chloroquine derivative conjugated to keyhole limpet haemocyanin and chloroquine conjugated to porcine thyroglobulin adsorbed onto the wells of a microtitration plate. The competitive binding of the antiserum to the wells was monitored using an alkaline-phosphatase-conjugated second antibody and a specific substrate. The assay exhibits no cross-reactivity with known chloroquine metabolites, other antimalarials, and commonly used drugs. The method was used to determine chloroquine in dried blood spot extracts and urine from a patient who was receiving a prescribed prophylactic chloroquine regimen. The drug was detected in the urine for 17 weeks and in the dried blood spots for 4 weeks after termination of the therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260830      PMCID: PMC2491053     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  11 in total

1.  [Determination of chloroquine in biological material by gas-liquid chromatography (author's transl)].

Authors:  A Viala; J P Cano; A Durand
Journal:  J Chromatogr       Date:  1975-09-03

2.  Rapid enzyme-linked immunosorbent assay (ELISA) with a visual end-point for detecting quinine in urine, serum and dried blood spots.

Authors:  V Rowell; F J Rowell
Journal:  Analyst       Date:  1987-10       Impact factor: 4.616

3.  Serum chloroquine levels in children before treatment for malaria.

Authors:  D Ofori-Adjei; J O Commey; K K Adjepon-Yamoah
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

4.  Improved fluorimetric assay of chloroquine in biological samples.

Authors:  S A Adelusi; L A Salako
Journal:  J Pharm Pharmacol       Date:  1980-10       Impact factor: 3.765

5.  Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection.

Authors:  L C Patchen; D L Mount; I K Schwartz; F C Churchill
Journal:  J Chromatogr       Date:  1983-11-11

6.  Direct determination of phenobarbital in serum or plasma by polarization fluoroimmunoassay.

Authors:  A M Sidki; M Pourfarzaneh; F J Rowell; D S Smith
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

7.  Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays.

Authors:  D Rodbard
Journal:  Anal Biochem       Date:  1978-10-01       Impact factor: 3.365

8.  A radioimmunoassay for the antimalarial drug chloroquine.

Authors:  C Freier; G Alberici; P Turk; F Baud; C Bohuon
Journal:  Clin Chem       Date:  1986-09       Impact factor: 8.327

9.  Disposition of chloroquine in man after single intravenous and oral doses.

Authors:  L L Gustafsson; O Walker; G Alván; B Beermann; F Estevez; L Gleisner; B Lindström; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

10.  Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper.

Authors:  B Lindström; O Ericsson; G Alván; L Rombo; L Ekman; M Rais; F Sjöqvist
Journal:  Ther Drug Monit       Date:  1985       Impact factor: 3.681

View more
  1 in total

1.  Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations.

Authors:  Insaf F Khalil; Michael Alifrangis; Camilla Recke; Lotte C Hoegberg; Anita Ronn; Ib C Bygbjerg; Claus Koch
Journal:  Malar J       Date:  2011-08-24       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.